The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
Open accessAbstract
Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies. The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion. Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology. In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis. These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Although members of the Jun and Fos families share a high degree of structural homology, the individual AP-1 dimers exert significant differences in their DNA binding affinity and their capability to activate or suppress gene expression [3].”
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
New therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Self-citationHan, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A. M., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12466 · Cited by 780
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
Self-citationPsoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Zenz, R., Eferl, R., Kenner, L., Florin, L., Hummerich, L., Mehic, D., Scheuch, H., Angel, P., Tschachler, E., & Wagner, E. F. (2005) · Nature · doi:10.1038/nature03963 · Cited by 599
Self-citationRecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Self-citationNuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
Matsuo, K., Galson, D. L., Zhao, C., Peng, L., Laplace, C., Wang, K. Z. Q., Bachler, M. A., Amano, H., Aburatani, H., Ishikawa, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313973200 · Cited by 501
Self-citationJun Turnover Is Controlled Through JNK-Dependent Phosphorylation of the E3 Ligase Itch
Gao, M., Labuda, T., Xia, Y., Gallagher, E., Fang, D., Liu, Y.-C., & Karin, M. (2004) · Science · doi:10.1126/science.1099414 · Cited by 397
Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis
Sabatakos, G., Sims, N. A., Chen, J., Aoki, K., Kelz, M. B., Amling, M., Bouali, Y., Mukhopadhyay, K., Ford, K., Nestler, E. J., et al. (2000) · Nature Medicine · doi:10.1038/79683 · Cited by 339
JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression
Passegue, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2969 · Cited by 332
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
Jochum, W., David, J.-P., Elliott, C., Wutz, A., Plenk, H., Matsuo, K., & Wagner, E. F. (2000) · Nature Medicine · doi:10.1038/79676 · Cited by 311
Self-citationc-Jun Regulates Eyelid Closure and Skin Tumor Development through EGFR Signaling
Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., & Wagner, E. F. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00161-8 · Cited by 279
Self-citationJunD Protects Cells from p53-Dependent Senescence and Apoptosis
Weitzman, J. B., Fiette, L., Matsuo, K., & Yaniv, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00109-x · Cited by 269
JunB is essential for mammalian placentation
Schorpp-Kistner, M., Wang, Z.-Q., Angel, P., & Wagner, E. F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.934 · Cited by 267
Self-citationGudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700807 · Cited by 266
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L., & Wagner, E. F. (2006) · Genes & Development · doi:10.1101/gad.390506 · Cited by 232
Self-citationMyeloid Cell Function in MRP-14 (S100A9) Null Mice
Hobbs, J. A. R., May, R., Tanousis, K., McNeill, E., Mathies, M., Gebhardt, C., Henderson, R., Robinson, M. J., & Hogg, N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2564-2576.2003 · Cited by 224
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
Kenner, L., Hoebertz, A., Beil, F. T., Keon, N., Karreth, F., Eferl, R., Scheuch, H., Szremska, A., Amling, M., Schorpp-Kistner, M., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200308155 · Cited by 208
Self-citationThe Fos‐related antigen Fra‐1 is an activator of bone matrix formation
Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M., & Wagner, E. F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600282 · Cited by 198
Self-citationThépot, D., Weitzman, J. B., Barra, J., Segretain, D., Stinnakre, M., Babinet, C., & Yaniv, M. (2000) · Development · doi:10.1242/dev.127.1.143 · Cited by 151
Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors
Zenz, R., & Wagner, E. F. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.011 · Cited by 147
Self-citationTh2 cell‐specific cytokine expression and allergen‐induced airway inflammation depend on JunB
Hartenstein, B., Teurich, S., Hess, J., Schenkel, J., Schorpp‐Kistner, M., & Angel, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf648 · Cited by 143
Inflammation-activated Protein Kinases as Targets for Drug Development
Karin, M. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-034sr · Cited by 137
JunD regulates lymphocyte proliferation and T helper cell cytokine expression
Meixner, A., Karreth, F. A., Kenner, L., & Wagner, E. F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600133 · Cited by 126
Self-citationRincón, M., Dérijard, B., Chow, C.-W., Davis, R. J., & Flavell, R. A. (1997) · Genes and Function · doi:10.1046/j.1365-4624.1997.00007.x · Cited by 113
T-cell regulation in rheumatoid arthritis
Goronzy, J. J., & Weyand, C. M. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00008 · Cited by 97
The AP1 transcription factor Fra2 is required for efficient cartilage development
Karreth, F. A., Hoebertz, A., Scheuch, H., Eferl, R., & Wagner, E. F. (2004) · Development · doi:10.1242/dev.01414 · Cited by 95
Self-citation(2000) · Nature Medicine · doi:10.1038/82242 · Cited by 67
Keratinocytes regain momentum as instigators of cutaneous inflammation
Nickoloff, B. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.01.001 · Cited by 61
Regulation of αβ/γδ T Cell Development by the Activator Protein 1 Transcription Factor c-Jun
Riera-Sans, L., & Behrens, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5690 · Cited by 47
Increased JunB mRNA and Protein Expression in Psoriasis Vulgaris Lesions
Haider, A. S., Fuentes‐Duculan, J., Whynot, J. A., & Krueger, J. G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700183 · Cited by 40
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion
O’Gradaigh, D., & Compston, J. E. (2003) · Rheumatology · doi:10.1093/rheumatology/keg447 · Cited by 38
Overexpression of fra-2 in transgenic mice perturbs normal eye development
McHenry, J. Z., Leon, A., MATTHAEI, K. I., & Cohén, D. (1998) · Oncogene · doi:10.1038/sj.onc.1202044 · Cited by 37
Johansen, C., Kragballe, K., Rasmussen, M. K., Dam, T. N., & Iversen, L. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06088.x · Cited by 34
Han, Z., Boyle, D. L., Chang, L., Bennett, B. L., Karin, M., Yang, L. C., Manning, A. M., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12466c1 · Cited by 23
Psoriasis-like Skin Disease and Arthritis Caused by Inducible Epidermal Deletion of Jun Proteins
THIERS, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70032-7 · Cited by 21
Animal models of psoriasis and psoriatic arthritis: An update
Conrad, C., & Nestle, F. O. (2006) · Current Rheumatology Reports · doi:10.1007/s11926-006-0063-x · Cited by 18
Autoimmunity and rheumatoid arthritis.
Js, S., Hayer, S., Schett, G., Redlich, K., Aringer, M., Kollias, G. A., Wagner, E., & Steiner, G. E. (2004) · PubMed · Cited by 12
Self-citation
Cited by
Mechanisms regulating skin immunity and inflammation
Pasparakis, M., Haase, I., & Nestle, F. O. (2014) · Nature Reviews Immunology · doi:10.1038/nri3646 · Cited by 886
Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance
Alipieva, K., Korkina, L., Orhan, I. E., & Georgiev, M. I. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.001 · Cited by 458
The AP-1 transcriptional complex: Local switch or remote command?
Bejjani, F., Evanno, E., Zibara, K., Piechaczyk, M., & Jariel-Encontre, I. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.003 · Cited by 352
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339
Muralidharan, S., & Mandrekar, P. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313153 · Cited by 329
Metadata
- Authors
- Zenz, R., Eferl, R., Scheinecker, C., Redlich, K., Smolen, J., Schonthaler, H. B., Kenner, L., Tschachler, E., & Wagner, E. F.
- Venue
- Arthritis Research & Therapy
- Published
- 2007
- Volume
- 10
- Issue
- 1
- Pages
- 201
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2141333281
- Cited by
- 350
- References
- 50
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.